Data Dictionary: ZfkD Cancer Registry (Germany) - Revision history

Larysse at 03:33, 3 December 2025

2025-12-03T03:33:13Z

← Older revision		Revision as of 03:33, 3 December 2025
Line 1:		Line 1:
	<span style="display:none">forresearchers</span>		<span style="display:none">forresearchers</span>
			<span style="display:none">germanycountry</span>
	Go back to [[Database: ZfKD Cancer Registry (Germany)]] page.		Go back to [[Database: ZfKD Cancer Registry (Germany)]] page.

Lucas: Update categories.

2025-12-02T13:27:17Z

Update categories.

← Older revision		Revision as of 13:27, 2 December 2025
Line 1:		Line 1:
	{{forresearchers}}		<span style="display:none">forresearchers</span>
	Go back to [[Database: ZfKD Cancer Registry (Germany)]] page.		Go back to [[Database: ZfKD Cancer Registry (Germany)]] page.

Victor at 20:24, 25 August 2024

2024-08-25T20:24:43Z

Francine at 17:05, 6 June 2024

2024-06-06T17:05:50Z

@@ Line 117: / Line 117: @@
 |-
 | Other classification system: stage || Stage assigned based on other classification system || Stage
 |}

Francine at 17:01, 6 June 2024

2024-06-06T17:01:40Z

Show changes

Francine at 14:05, 27 May 2024

2024-05-27T14:05:04Z

← Older revision		Revision as of 14:05, 27 May 2024
Line 1:		Line 1:
			{{forresearchers}}
	Go back to [[Database: ZfKD Cancer Registry (Germany)]] page.		Go back to [[Database: ZfKD Cancer Registry (Germany)]] page.

Francine at 19:59, 14 May 2024

2024-05-14T19:59:56Z

← Older revision		Revision as of 19:59, 14 May 2024
Line 1:		Line 1:
	Go back to [[Germany]] page.		Go back to [[Database: ZfKD Cancer Registry (Germany)]] page.

	Source: [https://www.krebsdaten.de/Krebs/DE/Content/Forschungsdaten/Informationen_datensatz/info_datensatz_node.html].		Source: [https://www.krebsdaten.de/Krebs/DE/Content/Forschungsdaten/Informationen_datensatz/info_datensatz_node.html Click here to learn more].

	{\| class="wikitable"		{\| class="wikitable"

Francine: Francine moved page Data dictionary: ZfkD Cancer Registry (Germany) to Data Dictionary: ZfkD Cancer Registry (Germany)

2024-05-14T19:56:56Z

Francine moved page Data dictionary: ZfkD Cancer Registry (Germany) to Data Dictionary: ZfkD Cancer Registry (Germany)

← Older revision	Revision as of 19:56, 14 May 2024
(No difference)

Larysse at 19:33, 12 December 2023

2023-12-12T19:33:34Z

← Older revision		Revision as of 19:33, 12 December 2023
Line 1:		Line 1:
	[https://www.krebsdaten.de/Krebs/DE/Content/Forschungsdaten/Informationen_datensatz/info_datensatz_node.html].		Go back to [[Germany]] page.

			Source: [https://www.krebsdaten.de/Krebs/DE/Content/Forschungsdaten/Informationen_datensatz/info_datensatz_node.html].

	{\| class="wikitable"		{\| class="wikitable"

Victor at 13:16, 9 November 2023

2023-11-09T13:16:10Z

← Older revision		Revision as of 13:16, 9 November 2023
Line 1:		Line 1:
			[https://www.krebsdaten.de/Krebs/DE/Content/Forschungsdaten/Informationen_datensatz/info_datensatz_node.html].

	{\| class="wikitable"		{\| class="wikitable"
	! Split !! Explanation		! Split !! Explanation

← Older revision		Revision as of 20:24, 25 August 2024
Line 24:		Line 24:
	\| Place of residence at diagnosis \|\| "Place of residence at diagnosis, represented by 2-digit area code (""Bundesland"")" \|\| 2-digit area code		\| Place of residence at diagnosis \|\| "Place of residence at diagnosis, represented by 2-digit area code (""Bundesland"")" \|\| 2-digit area code
	\|-		\|-
	\| ~~Tumor~~ diagnosis, ICD-10 code \|\| ICD-10 diagnostic code of ~~tumor~~ \|\| ICD-10, 4-digit code		\| Tumour diagnosis, ICD-10 code \|\| ICD-10 diagnostic code of tumour \|\| ICD-10, 4-digit code
	\|-		\|-
	\| ~~Tumor~~ diagnosis, ICD-10 version \|\| ICD-10 version used to encode ~~tumor~~ diagnosis \|\| ICD-10 version		\| Tumour diagnosis, ICD-10 version \|\| ICD-10 version used to encode tumour diagnosis \|\| ICD-10 version
	\|-		\|-
	\| Topography of ~~tumor~~, ICD-O-3 code \|\| ~~Tumor~~ site represented by ICD-O-3 topography code \|\| ICD-O-3 (topography section) 4-digit code		\| Topography of tumour, ICD-O-3 code \|\| Tumour site represented by ICD-O-3 topography code \|\| ICD-O-3 (topography section) 4-digit code
	\|-		\|-
	\| Morphology of ~~tumor~~, ICD-O-3 code \|\| Morphology and behavior of ~~tumor~~ represented by 5-digit ICD-O-3 code. The fifth digit indicates ~~tumor~~ behavior (/0 benign; /1 uncertain; /2 carcinoma in situ; /3 malignant). \|\| ICD-O-3 (morphology section), 5-digit code		\| Morphology of tumour, ICD-O-3 code \|\| Morphology and behavior of tumour represented by 5-digit ICD-O-3 code. The fifth digit indicates tumour behavior (/0 benign; /1 uncertain; /2 carcinoma in situ; /3 malignant). \|\| ICD-O-3 (morphology section), 5-digit code
	\|-		\|-
	\| Number of lymph nodes examined \|\| Number of lymph nodes that were examined for the presence of cancer cells \|\| (n) = number of lymph nodes		\| Number of lymph nodes examined \|\| Number of lymph nodes that were examined for the presence of cancer cells \|\| (n) = number of lymph nodes
Line 36:		Line 36:
	\| Number of lymph nodes affected \|\| Number of lymph nodes that contain cancer cells \|\| (n) = number of lymph nodes		\| Number of lymph nodes affected \|\| Number of lymph nodes that contain cancer cells \|\| (n) = number of lymph nodes
	\|-		\|-
	\| cTNM: T \|\| Describes the size of the primary ~~tumor~~. Staging according to ~~tumor~~-specific TNM. \|\| T stage, ~~tumor~~-specific		\| cTNM: T \|\| Describes the size of the primary tumour. Staging according to tumour-specific TNM. \|\| T stage, tumour-specific
	\|-		\|-
	\| cTNM: N \|\| Describes the degree of spread to regional lymph nodes. Staging according to ~~tumor~~-specific TNM. \|\| N stage, ~~tumor~~-specific		\| cTNM: N \|\| Describes the degree of spread to regional lymph nodes. Staging according to tumour-specific TNM. \|\| N stage, tumour-specific
	\|-		\|-
	\| cTNM: UICC Stage \|\| UICC Stage according to TNM. Describes the anatomical extent of disease. \|\| UICC stage, ~~tumor~~-specific		\| cTNM: UICC Stage \|\| UICC Stage according to TNM. Describes the anatomical extent of disease. \|\| UICC stage, tumour-specific
	\|-		\|-
	\| pTNM: T \|\| Describes the size of the primary ~~tumor~~. Staging according to ~~tumor~~-specific TNM. \|\| T stage, ~~tumor~~-specific		\| pTNM: T \|\| Describes the size of the primary tumour. Staging according to tumour-specific TNM. \|\| T stage, tumour-specific
	\|-		\|-
	\| pTNM: N \|\| Describes the degree of spread to regional lymph nodes. Staging according to ~~tumor~~-specific TNM. \|\| N stage, ~~tumor~~-specific		\| pTNM: N \|\| Describes the degree of spread to regional lymph nodes. Staging according to tumour-specific TNM. \|\| N stage, tumour-specific
	\|-		\|-
	\| pTNM: UICC stage \|\| UICC Stage according to TNM. Describes the anatomical extent of disease. \|\| UICC stage, ~~tumor~~-specific		\| pTNM: UICC stage \|\| UICC Stage according to TNM. Describes the anatomical extent of disease. \|\| UICC stage, tumour-specific
	\|-		\|-
	\| Other classification system: name \|\| Name and/or type of other classification(s) used \|\| e.g. Ann Arbor staging, WHO Classification of CNS ~~Tumors~~, AJCC		\| Other classification system: name \|\| Name and/or type of other classification(s) used \|\| e.g. Ann Arbor staging, WHO Classification of CNS Tumours, AJCC
	\|-		\|-
	\| Other classification system: stage \|\| Stage assigned based on other classification system \|\| Stage		\| Other classification system: stage \|\| Stage assigned based on other classification system \|\| Stage
Line 54:		Line 54:
	\| Survival time \|\| Time interval between incidence date and death \|\| (n) = number of days		\| Survival time \|\| Time interval between incidence date and death \|\| (n) = number of days
	\|-		\|-
	\| ~~Tumor~~ size \|\| Maximum diameter of invasive carcinoma (in mm) \|\| (n) = ~~tumor~~ size in mm		\| Tumour size \|\| Maximum diameter of invasive carcinoma (in mm) \|\| (n) = tumour size in mm
	\|-		\|-
	\| DCIS size \|\| Maximum diameter of ductal carcinoma in situ (in mm) \|\| (n) = DCIS size in mm		\| DCIS size \|\| Maximum diameter of ductal carcinoma in situ (in mm) \|\| (n) = DCIS size in mm
Line 68:		Line 68:
	\| Gleason score \|\| Gleason score \|\| 2, 3, 4, 5, 6, 7, 7a, 7b, 8, 9 or 10		\| Gleason score \|\| Gleason score \|\| 2, 3, 4, 5, 6, 7, 7a, 7b, 8, 9 or 10
	\|-		\|-
	\| ~~Tumor~~ thickness \|\| Thickness of ~~tumor~~ (mm) \|\| (n) = thickness in mm		\| Tumour thickness \|\| Thickness of tumour (mm) \|\| (n) = thickness in mm
	\|-		\|-
	\| LDH level \|\| LDH level (units per liter) \|\| (n) = level in U/L		\| LDH level \|\| LDH level (units per liter) \|\| (n) = level in U/L
Line 106:		Line 106:
	\| Time to systemic therapy \|\| Time interval between incidence date and systemic therapy start date (days) \|\| (n) = number of days		\| Time to systemic therapy \|\| Time interval between incidence date and systemic therapy start date (days) \|\| (n) = number of days
	\|-		\|-
	\| Follow-up date \|\| Date of most recent follow-up evaluation of ~~tumor~~ status \|\| Date YYYY-MM-DD		\| Follow-up date \|\| Date of most recent follow-up evaluation of tumour status \|\| Date YYYY-MM-DD
	\|-		\|-
	\| TNM: T \|\| Describes the size of the primary ~~tumor~~. Staging according to ~~tumor~~-specific TNM. \|\| T stage, ~~tumor~~-specific		\| TNM: T \|\| Describes the size of the primary tumour. Staging according to tumour-specific TNM. \|\| T stage, tumour-specific
	\|-		\|-
	\| TNM: N \|\| Describes the degree of spread to regional lymph nodes. Staging according to ~~tumor~~-specific TNM. \|\| N stage, ~~tumor~~-specific		\| TNM: N \|\| Describes the degree of spread to regional lymph nodes. Staging according to tumour-specific TNM. \|\| N stage, tumour-specific
	\|-		\|-
	\| TNM: UICC stage \|\| UICC Stage at follow-up according to TNM. Describes the anatomical extent of disease. \|\| UICC stage, ~~tumor~~-specific		\| TNM: UICC stage \|\| UICC Stage at follow-up according to TNM. Describes the anatomical extent of disease. \|\| UICC stage, tumour-specific
	\|-		\|-
	\| Other classification system: name \|\| Name and/or type of other classification(s) used \|\| e.g. Ann Arbor staging, WHO Classification of CNS ~~Tumors~~, AJCC		\| Other classification system: name \|\| Name and/or type of other classification(s) used \|\| e.g. Ann Arbor staging, WHO Classification of CNS Tumours, AJCC
	\|-		\|-
	\| Other classification system: stage \|\| Stage assigned based on other classification system \|\| Stage		\| Other classification system: stage \|\| Stage assigned based on other classification system \|\| Stage
	{\| class="wikitable"		{\| class="wikitable"
	! Basis of diagnosis !! Describes how the ~~tumor~~ was identified !! "0 = death certificate only (DCO);		! Basis of diagnosis !! Describes how the tumour was identified !! "0 = death certificate only (DCO);
	\|-		\|-
	\| 1 = clinical, ie physical exam only (no ~~tumor~~-specific diagnostics); \|\| \|\|		\| 1 = clinical, ie physical exam only (no tumour-specific diagnostics); \|\| \|\|
	\|-		\|-
	\| 2 = clinical investigation using diagnostic techniques such as imaging, endoscopy, laparatomy, autopsy (no histopathology); \|\| \|\|		\| 2 = clinical investigation using diagnostic techniques such as imaging, endoscopy, laparatomy, autopsy (no histopathology); \|\| \|\|
	\|-		\|-
	\| 4 = specific ~~tumor~~ markers; \|\| \|\|		\| 4 = specific tumour markers; \|\| \|\|
	\|-		\|-
	\| 5 = cytology; \|\| \|\|		\| 5 = cytology; \|\| \|\|
Line 130:		Line 130:
	\| 6 = histopathology, metastasis; \|\| \|\|		\| 6 = histopathology, metastasis; \|\| \|\|
	\|-		\|-
	\| 7 = histopathology, primary ~~tumor~~; \|\| \|\|		\| 7 = histopathology, primary tumour; \|\| \|\|
	\|-		\|-
	\| 9 = unknown" \|\| \|\|		\| 9 = unknown" \|\| \|\|
	\|-		\|-
	\| ~~Tumor~~ laterality \|\| Describes which side of a paired organ is affected \|\| "L = left;		\| Tumour laterality \|\| Describes which side of a paired organ is affected \|\| "L = left;
	\|-		\|-
	\| R = right; \|\| \|\|		\| R = right; \|\| \|\|
Line 152:		Line 152:
	\| Survival time \|\| Time interval between incidence date and death \|\| (n) = number of days		\| Survival time \|\| Time interval between incidence date and death \|\| (n) = number of days
	\|-		\|-
	\| ~~Tumor~~ size \|\| Maximum diameter of invasive carcinoma (in mm) \|\| (n) = ~~tumor~~ size in mm		\| Tumour size \|\| Maximum diameter of invasive carcinoma (in mm) \|\| (n) = tumour size in mm
	\|-		\|-
	\| DCIS size \|\| Maximum diameter of ductal carcinoma in situ (in mm) \|\| (n) = DCIS size in mm		\| DCIS size \|\| Maximum diameter of ductal carcinoma in situ (in mm) \|\| (n) = DCIS size in mm
Line 202:		Line 202:
	\| U = unknown" \|\| \|\|		\| U = unknown" \|\| \|\|
	\|-		\|-
	\| ~~Tumor~~ thickness \|\| Thickness of ~~tumor~~ (mm) \|\| (n) = thickness in mm		\| Tumour thickness \|\| Thickness of tumour (mm) \|\| (n) = thickness in mm
	\|-		\|-
	\| Ulceration \|\| Indicates whether or not ulceration is present. \|\| "J = Yes;		\| Ulceration \|\| Indicates whether or not ulceration is present. \|\| "J = Yes;
Line 210:		Line 210:
	\| LDH level \|\| LDH level (units per liter) \|\| (n) = level in U/L		\| LDH level \|\| LDH level (units per liter) \|\| (n) = level in U/L
	\|-		\|-
	\| Position \|\| Rectal carcinoma: Distance between anocutaneous line and aboral ~~tumor~~ margin (in cm) \|\| "(n) = distance from anocutaneous line in cm;		\| Position \|\| Rectal carcinoma: Distance between anocutaneous line and aboral tumour margin (in cm) \|\| "(n) = distance from anocutaneous line in cm;
	\|-		\|-
	\| U = unknown" \|\| \|\|		\| U = unknown" \|\| \|\|